Cardiovascular variability analysis. An insight into the pathophysiology of cardiovascular disease and the impact of treatment. With caution

Clinical Autonomic Research

Volumn 12, Issue 1, 2002, Pages 4-8

  Parati, Gianfranco ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; DATA ANALYSIS; EDITORIAL; HEART RATE VARIABILITY; NEUROMODULATION; PATHOPHYSIOLOGY; SYMPATHECTOMY;

EID: 0036250152     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102860200002     Document Type: Editorial

References (58)

1. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control
2. Cardiovascular neural regulation explored in the frequency domain
3. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: A critical appraisal
4. Neural cardiovascular regulation and 24-hour blood pressure and heart rate variability
5. 24 h sequential spectral analysis of arterial blood pressure and pulse interval in free-moving subjects
6. Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans
7. Continuous 24-hour assessment of neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects
8. Spectral analysis of blood pressure and heart rate variability in autonomic disorders
9. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings
10. Prolonged intra-arterial blood pressure recording in the diagnosis of phaeochromocytoma
11. Parameter extraction from heart rate and arterial blood pressure variability signals in dogs for the validation of a physiological model
12. Effects of sino-aortic denervation on spectral characteristic of blood pressure and pulse interval variability: A wide-band approach
13. Identification of major slow blood pressure oscillations in conscious dogs
14. Autonomic nervous system and cardiovascular variability in rats: A spectral analysis approach
15. Analysis of long term heart rate variability: Methods, 1/f scaling and implications
16. Closed-loop identification of blood pressure variability mechanisms
17. Spectral decomposition in multichannel recordings based on multivariate parametric identification
18. Closed-loop versus open-loop assessment of heart rate baroreflex
19. A new method for evaluating the baroreflex role by a joint pattern analysis of pulse interval and systolic blood pressure series
20. Assessment of baroreceptor reflex sensitivity by means of spectral analysis
21. Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans
22. Baroreflex gain: Characterization using autoregressive moving average analysis
23. Effects of aging on 24 hour dynamic baroreceptor control of heart rate in ambulant subjects
24. How to measure baroreflex sensitivity: From the cardiovascular laboratory to daily life
25. Evaluation of baroreceptors reflex by blood pressure monitoring in unanesthetized cats
26. Changes in autonomic regulation induced by physical training in mild hypertension
27. Photoelectric measurement of blood pressure, volume and flow in the finger (abst)
28. Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing
29. Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording
30. Spectral and sequence analysis of finger blood pressure variability: Comparison with analysis of intra-arterial recordings
31. Broad-band spectral analysis of 24-hour continuous finger blood pressure: Comparison with ambulatory intra-arterial recordings
32. A Comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients
33. Sympathectomy, sinoaortic denervation and spectral powers of blood pressure and heart rate in Lyon rats
34. Effect of sympathectomy on blood pressure variability in the conscious rat
35. Short-term haemodynamic variability in the conscious areflexic rat
36. Involvement of vasodilator mechanisms in arterial pressure lability after sinoaortic baroreceptor denervation in rat
37. Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus
38. Smoking impairs baroreflex sensitivity in humans
39. Thoracic sympathectomy: Effects on hemodynamics and barorefelx control
40. Relationship between spectral components of cardiovascular variabilities and direct measures of muscle sympathetic nerve activity in humans
41. Differential regulation of the oscillations in sympathetic nerve activity and renal blood flow following volume expansion
42. Frequency-response characteristics of autonomic nervous system function in conscious rats
43. Baro-modulation explains short-term blood pressure variability
44. Respiratory modulation of blood pressure and heart rate studied with a computer model of baroreflex control
45. Effects of epidural analgesia and atropine on heart rate and blood pressure variability: Implications for the interpretation of beat-to-beat fluctuations
46. Power spectral analysis of heart rate variability in traumatic quadriplegic humans
47. Power spectral analysis of blood pressure variability in traumatic quadriplegic humans
48. Variabilità di pressione arteriosa e frequenza cardiaca e sensibilità barocettiva in soggetti con lesione al midollo
49. The arterial baroreceptor reflex of the rat exhibits positive feedback properties at the frequency of Mayer waves
50. Cardiovascular sympathetic afferents
51. Potentiation of the baroreceptor-heart rate reflex by sympathectomy in conscious rats
52. Blood pressure variability
53. Low power, type II errors, and other statistical problems in recent cardiovascualr research
54. Techniques for Studying short-term changes in cardio-respiratory data, II
55. Early diagnosis of diabetic autonomic neuropathy. Present and future approaches
56. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Implications for clinical trials